TPH1
Basic information
Region (hg38): 11:18017555-18046269
Previous symbols: [ "TPRH", "TPH" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TPH1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 18 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 1 | 3 |
Variants in TPH1
This is a list of pathogenic ClinVar variants found in the TPH1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-18021028-T-C | not specified | Uncertain significance (Aug 30, 2021) | ||
11-18021050-G-C | not specified | Conflicting classifications of pathogenicity (Dec 16, 2022) | ||
11-18021090-T-A | not specified | Uncertain significance (May 30, 2023) | ||
11-18021109-C-T | not specified | Likely benign (May 07, 2024) | ||
11-18021143-G-A | Uncertain significance (Jan 12, 2022) | |||
11-18021145-T-C | not specified | Uncertain significance (May 30, 2023) | ||
11-18022863-A-G | Benign (Jul 13, 2018) | |||
11-18022915-T-C | not specified | Uncertain significance (Mar 24, 2023) | ||
11-18022925-G-A | not specified | Uncertain significance (Jun 03, 2024) | ||
11-18025669-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
11-18025708-G-T | TPH1-related disorder | Benign (Oct 18, 2019) | ||
11-18026502-T-C | not specified | Uncertain significance (Sep 16, 2021) | ||
11-18026508-G-T | not specified | Uncertain significance (May 31, 2023) | ||
11-18026622-C-T | not specified | Uncertain significance (Mar 13, 2023) | ||
11-18026623-G-A | not specified | Uncertain significance (Jun 13, 2024) | ||
11-18029176-T-C | not specified | Uncertain significance (Jun 29, 2022) | ||
11-18029259-T-G | not specified | Uncertain significance (May 24, 2023) | ||
11-18029303-C-T | Likely benign (Apr 01, 2023) | |||
11-18029548-C-T | not specified | Uncertain significance (Sep 13, 2023) | ||
11-18029549-G-A | TPH1-related disorder | Uncertain significance (Sep 21, 2024) | ||
11-18029551-C-T | not specified | Uncertain significance (Dec 06, 2022) | ||
11-18033286-A-T | not specified | Uncertain significance (Jan 23, 2024) | ||
11-18033287-T-C | not specified | Uncertain significance (Dec 13, 2021) | ||
11-18033296-G-T | not specified | Uncertain significance (Jan 23, 2024) | ||
11-18033364-AGTTTCCATACCT-A | Uncertain significance (May 31, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TPH1 | protein_coding | protein_coding | ENST00000250018 | 10 | 24863 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
3.19e-7 | 0.934 | 125591 | 0 | 157 | 125748 | 0.000624 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.734 | 204 | 236 | 0.865 | 0.0000123 | 2941 |
Missense in Polyphen | 80 | 92.38 | 0.86599 | 1111 | ||
Synonymous | 0.159 | 82 | 83.9 | 0.978 | 0.00000420 | 818 |
Loss of Function | 1.81 | 14 | 23.5 | 0.597 | 0.00000131 | 296 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00142 | 0.00142 |
Ashkenazi Jewish | 0.000101 | 0.0000992 |
East Asian | 0.00163 | 0.00163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000766 | 0.000765 |
Middle Eastern | 0.00163 | 0.00163 |
South Asian | 0.000229 | 0.000229 |
Other | 0.000491 | 0.000489 |
dbNSFP
Source:
- Pathway
- Folate biosynthesis - Homo sapiens (human);Tryptophan metabolism - Homo sapiens (human);Serotonergic synapse - Homo sapiens (human);Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics;Tryptophan Metabolism;Amino Acid metabolism;Tryptophan metabolism;Biogenic Amine Synthesis;Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways;serotonin and melatonin biosynthesis;Metabolism of amino acids and derivatives;Metabolism;Tryptophan degradation;superpathway of tryptophan utilization;Serotonin and melatonin biosynthesis;Amine-derived hormones
(Consensus)
Recessive Scores
- pRec
- 0.396
Intolerance Scores
- loftool
- 0.354
- rvis_EVS
- -0.38
- rvis_percentile_EVS
- 28.01
Haploinsufficiency Scores
- pHI
- 0.429
- hipred
- N
- hipred_score
- 0.369
- ghis
- 0.478
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.987
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tph1
- Phenotype
- skeleton phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- tph1b
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- decreased weight
Gene ontology
- Biological process
- circadian rhythm;aromatic amino acid family metabolic process;negative regulation of ossification;response to immobilization stress;serotonin biosynthetic process;positive regulation of fat cell differentiation;bone remodeling;oxidation-reduction process;mammary gland alveolus development
- Cellular component
- cytosol;neuron projection
- Molecular function
- tryptophan 5-monooxygenase activity;iron ion binding